Along with the inhibition of PLK1 and UBE2C expression, the phosphorylation of histone H3 on Ser-10 (an epigenetic mitotic marker) was also inhibited by HO-1089 treatment in HCC cells (Figure 4C). Here, UBE2C is linked to hepatocellular carcinoma.